Researchers at the University of California, Davis have developed a peptide nucleic acid-based system enabling precise and customizable delivery of antigens, adjuvants, and targeting molecules for improved cancer immunotherapy.

Researchers at the University of California, Davis have developed novel serotonin receptor modulators designed as mixed 5-HT2A/2C partial agonists that demonstrate promising disease-modifying potential for Parkinson’s Disease with improved safety and efficacy.

Researchers at the University of California, Davis have developed a novel class of compounds for modulating serotonin receptors, offering potential treatment for various psychiatric and neurological disorders without inducing hallucinogenic effects.

Researchers at the University of California, Davis have developed a portable apparatus that standardizes digit positioning and applies counter-resistance for improved imaging of the flexor tendon system in the hand.

Researchers at the University of California, Davis have developed an aluminum catalyst that enables fast, base-free transfer hydrogenation of aldehydes and ketones using isopropanol as a hydrogen source.

Researchers at the University of California, Davis have developed a system of reusable, sterilizable 3D-printed surgical tools that enables safe, precise intraoperative deployment of Neuropixels probes within standard neurosurgical workflows.

Researchers at the University of California, Davis have developed a nanoreactor that allows for accurate measurements of radiation dose even in the vicinity of other chemicals.

Researchers at the University of California, Davis have developed a method for producing aligned, food-grade hydrogel fibers at high throughput for scalable cultivated meat manufacturing.